Lilly(Eli) & Co

NYSE:LLY   10:23:40 AM EDT
244.00
-2.33 (-0.95%)
Products

FDA Accepts Supplemental New Drug Application And Grants Priority Review For Jardiance

Published: 11/11/2021 18:40 GMT
Lilly(Eli) & Co (LLY) - Us FDA Accepts Supplemental New Drug Application and Grants Priority Review for Jardiance® for Adults With Heart Failure Independent of Left Ventricular Ejection Fraction.
Eli Lilly - Snda is Based on Results From Emperor-preserved Phase Iii Trial.